Clinical Trial Update: ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update for an ER+/HER2- breast cancer candidate (ENZENO) in locally advanced or metastatic disease; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• ENZENO

Snippet

Sponsor: EnhancedBio USA Inc. | Conditions: Estrogen Receptor-Positive, HER2-Negative | Phase 1, Phase 2 | Status: UNKNOWN